Firms

Altara Ventures

Singapore

sg.linkedin.com

Altara Ventures is a Singapore-based venture capital firm backing early-stage companies across Southeast Asia, South Korea and selected global markets, including the United States and India. It typically leads Series A and Series B rounds and supports founders through board participation and operating experience. Its strategy spans financial services, consumer platforms, enterprise software, healthcare, supply chains and education. Relevant published investments include Senseye’s ocular analytics and machine-learning research for mental-health assessment, AI-driven mathematics education company Clevai, enterprise software provider Servis.ai, and healthcare companies Kyan, Med247, Klinik Pintar and Reach52. The firm launched in2020; the underlying Altara Ventures Fund L.P. was formed in2019 and formerly named Credence Ventures Fund L.P., according to its SEC filing. Its current own portfolio attributes Senseye’s Series A investment to2019, a predecessor-era date. The exact legal investor vehicle for that historical investment is not asserted from the later brand alone. The firm’s published USD130M assets under management and USD3–5M initial check range are distinct from independently verified fund closings and individual portfolio tickets.

Founded: 2020
Type: Venture capital

Funds1

Altara Ventures Fund L.P. (formerly Credence Ventures Fund L.P.)—$4M
Historical reported subscriptions as of the document signed January22,2021: USD4M of limited partnership interests sold to one investor, with first sale January7,2021. This is an interim regulatory amount rather than final fund size or proof that all commitments were called. USD200M was the offering target. Secondary reporting later identifies a USD130M final close inFebruary2022, but no direct original closing announcement was recovered; the current firm’s USD130M AUM is not substituted for a primary-confirmed final fund closing.